标题
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis
作者
关键词
-
出版物
Science Translational Medicine
Volume 4, Issue 150, Pages 150ra121-150ra121
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2012-09-06
DOI
10.1126/scitranslmed.3004395
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010
- (2012) Matteo Zignol et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future
- (2012) Christian Lienhardt et al. JOURNAL OF INFECTIOUS DISEASES
- Improvement of molecular-replacement models withSculptor
- (2011) Gábor Bunkóczi et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Presenting your structures: theCCP4mgmolecular-graphics software
- (2011) S. McNicholas et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- New tuberculosis drugs on the horizon
- (2011) Stewart T Cole et al. CURRENT OPINION IN MICROBIOLOGY
- Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2′-Oxidase DprE1
- (2011) Claudia Trefzer et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Decaprenylphosphoryl-β-D-Ribose 2′-Epimerase, the Target of Benzothiazinones and Dinitrobenzamides, Is an Essential Enzyme in Mycobacterium smegmatis
- (2011) Paul K. Crellin et al. PLoS One
- Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis
- (2011) Ana Luisa de Jesus Lopes Ribeiro et al. PLoS One
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals Are Uniformly Susceptible to Benzothiazinones
- (2010) M. R. Pasca et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Decaprenylphosphoryl-β-D-Ribose 2-Epimerase from Mycobacterium tuberculosis is a Magic Drug Target
- (2010) G. Manina et al. CURRENT MEDICINAL CHEMISTRY
- Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-β-d-ribose 2′-epimerase DprE1 ofMycobacterium tuberculosis
- (2010) Claudia Trefzer et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Leads for antitubercular compounds from kinase inhibitor library screens
- (2010) Sophie Magnet et al. TUBERCULOSIS
- Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level
- (2009) A. A. Velayati et al. EUROPEAN RESPIRATORY JOURNAL
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors
- (2009) Thierry Christophe et al. PLoS Pathogens
- Biosynthesis of D-arabinose in mycobacteria - a novel bacterial pathway with implications for antimycobacterial therapy
- (2008) Beata A. Wolucka FEBS Journal
- Structural Analysis of the Catalytic Mechanism and Stereoselectivity inStreptomyces coelicolorAlditol Oxidase†,‡
- (2007) Federico Forneris et al. BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now